StockData
Pulmatrix, Inc. logo

Pulmatrix, Inc. (PULM) stock

PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.33+0.04 (+3.10%)

Close on Nov 16, 2026Market cap $4.86MP/E –Yield –

Pulmatrix gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Pulmatrix

Pulmatrix has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Pulmatrix figures

See a number that looks wrong?